Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug520 | Base therapy Wiki | 1.00 |
| drug660 | Bromhexine and Spironolactone Wiki | 1.00 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| D045169 | Severe Acute Respiratory Syndrome NIH | 0.04 |
| D018352 | Coronavirus Infections NIH | 0.04 |
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
Documentation of all patients undergoing inpatient treatment for SARS-CoV-2 infection with regard to clinical status at admission, medical history, inpatient treatment and course of disease. The aim is to create a risk stratification of the infection on the basis of clinical data as well as therapy and disease progression of the patients. This may also contribute to a better planning of resources.
Description: presence of infiltrates
Measure: Chest x-ray Time: throughout study completion, in average 1.5 yearsDescription: presence of infiltrates
Measure: Chest CT Time: throughout study completion, in average 1.5 yearsDescription: number of patients with ICU treatment required
Measure: Supportive care - ICU Time: throughout study completion, in average 1.5 yearsDescription: number of patients with oxygen therapy required
Measure: Supportive care - oxygen therapy Time: throughout study completion, in average 1.5 yearsDescription: number of patients with ventilation required
Measure: Supportive care - ventilation Time: throughout study completion, in average 1.5 yearsDescription: number of patients with medication changes
Measure: Medication Time: throughout study completion, in average 1.5 yearsDescription: number of patients with ECMO required
Measure: Therapeutic strategies Time: throughout study completion, in average 1.5 yearsDescription: number of patients with significant changes in lab parameters
Measure: Lab parameters Time: throughout study completion, in average 1.5 yearsDescription: number of patients with complications during hospital stay
Measure: Intra-hospital complications Time: throughout study completion, in average 1.5 yearsDescription: vital status at discharge: alive, dead
Measure: Vital status at discharge Time: throughout study completion, in average 1.5 yearsAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports